BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11552252)

  • 1. [Misoprostol in gynecology and obstetrics].
    Halmesmäki E; Nuutila M
    Duodecim; 1998; 114(14):1422-4. PubMed ID: 11552252
    [No Abstract]   [Full Text] [Related]  

  • 2. [Misoprostol--a new prostaglandin in obstetrical practice].
    Katsulov A; Todorova Ts
    Akush Ginekol (Sofiia); 1998; 37(2):59-66. PubMed ID: 9859543
    [No Abstract]   [Full Text] [Related]  

  • 3. [Status and expertise of off-label use of misoprostol in obstetrics and gynecology in France: study by CNGOF (short text)].
    Marret H; Simon E; Beucher G; Dreyfus M; Gaudineau A; Vayssière C; Lesavre M; Pluchon M; Winer N; Fernandez H; Aubert J; Bejan-Angoulvant T; Jonville-Bera AP; Clouqueur E; Houfflin-Debarge V; Garrigue A; Pierre F;
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):107-13. PubMed ID: 24438770
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of misoprostol in pregnancy.
    Hale RW; Zinberg S
    N Engl J Med; 2001 Jan; 344(1):59-60. PubMed ID: 11136964
    [No Abstract]   [Full Text] [Related]  

  • 5. [Off-label use of misoprostol in obstetrics and gynecology: methods and organization].
    Simon EG; Fritel X
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):103-6. PubMed ID: 24440127
    [No Abstract]   [Full Text] [Related]  

  • 6. [Off-label use of misoprostol in obstetrics and gynecology: Introduction].
    Simon EG; Marret H
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):87-102. PubMed ID: 24440000
    [No Abstract]   [Full Text] [Related]  

  • 7. Misoprostol and pregnancy.
    Goldberg AB; Greenberg MB; Darney PD
    N Engl J Med; 2001 Jan; 344(1):38-47. PubMed ID: 11136959
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical uses of misoprostol in obstetrics and gynecology].
    Yu J; Zhang J; Song Y
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):55-7. PubMed ID: 10682459
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy and safety of misoprostol in obstetrics].
    Capilla Montes C; Bermejo Vicedo T
    Farm Hosp; 2005; 29(3):177-84. PubMed ID: 16013944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misoprostol: a quarter century of use, abuse, and creative misuse.
    Chong YS; Su LL; Arulkumaran S
    Obstet Gynecol Surv; 2004 Feb; 59(2):128-40. PubMed ID: 14752301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misoprostol and pregnancy: ever-increasing indications of effective usage.
    Lokugamage AU; Refaey HE; Rodeck CH
    Curr Opin Obstet Gynecol; 2003 Dec; 15(6):513-8. PubMed ID: 14624219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of dilation and evacuation versus the induction of labor for second-trimester pregnancy termination.
    Cowett AA; Golub RM; Grobman WA
    Am J Obstet Gynecol; 2006 Mar; 194(3):768-73. PubMed ID: 16522411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of misoprostol in gynecology and obstetrics].
    Béchard de Spirlet M
    Gynecol Obstet Fertil; 2002 Apr; 30(4):317-24. PubMed ID: 12043508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misoprostol and the politics of fear.
    Mackenzie WE
    Lancet; 2001 Apr; 357(9264):1296. PubMed ID: 11424281
    [No Abstract]   [Full Text] [Related]  

  • 15. ["Off label" use of some medicinal products. Part II. "Off label" use of misoprostol].
    Sirakov M
    Akush Ginekol (Sofiia); 2012; 51(3):50-4. PubMed ID: 23236666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of intravenous oxytocin to vaginal misoprostol for mid trimester labor induction.
    Hidar S; Jerbi M; Khaïri H
    Am J Obstet Gynecol; 2006 Jul; 195(1):332-3; author reply 333-4. PubMed ID: 16813766
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of labour at term--misoprostol, efficacy, economics and ethics.
    Howarth GR; Pistorius L; Mantel G; Funk M; Pattinson RC
    S Afr Med J; 1996 Sep; 86(9 Suppl):1174, 1176. PubMed ID: 9180779
    [No Abstract]   [Full Text] [Related]  

  • 18. [Misoprostol off label essential for women's health].
    Danielsson KG
    Lakartidningen; 2013 Nov 13-19; 110(46):2045-6. PubMed ID: 24380157
    [No Abstract]   [Full Text] [Related]  

  • 19. WHO recommendations for misoprostol use for obstetric and gynecologic indications.
    Tang J; Kapp N; Dragoman M; de Souza JP
    Int J Gynaecol Obstet; 2013 May; 121(2):186-9. PubMed ID: 23433680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manufacturer's warning regarding unapproved uses of misoprostol.
    Friedman MA
    N Engl J Med; 2001 Jan; 344(1):61. PubMed ID: 11187113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.